You are here

  • Home
  • Archive
  • Volume 27, Issue 7
  • Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort

Article info

Article menu
Download PDFPDF
Uterine Cancer
Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort

Authors

  • Rhonda Farrell Royal Hospital for Women and Prince of Wales Private Hospital, Sydney, New South Wales; PubMed articlesGoogle scholar articles
  • Suzanne C. Dixon Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute; School of Public Health, University of Queensland, Brisbane, Queensland; PubMed articlesGoogle scholar articles
  • Jonathan Carter Gynaecological Cancer Centre, Chris O’Brien Lifehouse, Sydney, New South Wales; and PubMed articlesGoogle scholar articles
  • Penny M. Webb Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute; School of Public Health, University of Queensland, Brisbane, Queensland; Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Rhonda Farrell, MS, Royal Hospital for Women and Prince of Wales Private Hospital, Suite 30, Level 7, Prince of Wales Private Hospital, Randwick, Sydney, New South Wales, Australia 2031. E-mail: rhondafarrell{at}mac.com.

Citation

Farrell R, Dixon SC, Carter J, et al
Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort
International Journal of Gynecologic Cancer 2017;27:1379-1386.

Publication history

  • Received September 18, 2016
  • Accepted April 13, 2017
  • First published September 1, 2017.
Online issue publication 
January 27, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.